Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III palbociclib in high-risk hormone receptor-positive, HER2-negative primary breast cancer after neoadjuvant chemotherapy
KCT0003217Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by GBG Forschungs. Started Oct 2014; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0003217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003217.